Skip to content

Home › In Vitro Models

In Vitro Models

Our scientific experts have validated and optimised our complex and functional tissue models for several applications within the drug development process

Predictive models used in our services or available to purchase as a product

retina

Retina Models

Models of the neural retinal (retinal organoids) and the retinal pigmented epithelium (RPE) for use in modelling retinopathies and safety studies.

Find out more
kidney

Models of the Kidney Nephron

Models of the proximal tubule and of the glomerulus for drug transporter, nephrotoxicity and disease modelling studies.

Find out more
lungs

Lung Airway Models

Models of the small airway and lung fibrosis model for drug efficacy testing and lung toxicity testing.

Find out more

Who we are

We are a team of globally recognised experts in building and applying complex models of human tissues for drug discovery.

We are cell biologists, tissue physiologists, bioegineers and assay development scientists focused on building models that balance complexity, functionality, throughput and efficiency to improve the predictive power of in vitro data.

Find out more

What we do

We carry out bespoke efficacy, safety, disease modelling and membrane transporter kinetics studies on our models and provide products that enable customers to generate data to de-risk drug discovery and development.

Our experts collaborate with customers to design studies to provide data that answer their critical questions in pre-clinical drug development. We run the study and provide you with data interpretation or we can supply products for you to run in-house studies.

Find out more

Our Commitment

To improve the success of in vitro to clinical trials translation by developing and validating in vitro models for biomedical research.

We aim to contribute to the development of new innovative therapies by delivering services, products and tools based on our models of human tissues that provide data that informs and predicts how these therapies will behave in humans. Through the wider adoption of this approach, our work will advance the 3R’s policy in drug development.

Find out more

Get our latest updates straight to your inbox